osteoblastic cells
Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells
11
Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells
9
Activated parathyroid hormone/parathyroid hormone–related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone
11
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells
6
Porcine placenta hydrolysates regulate calcium disturbance in MC3T3 E1 osteoblastic cells
10
Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells
8
Effects of Alendronate on Human Alveolar Osteoblastic Cells: Interactions with Platelet- Derived Growth Factor
6
Effect of Lycopene Supplementation on Osteoblastic Cells
8
Interleukin 6 attenuates agonist mediated calcium mobilization in murine osteoblastic cells
12
Behavior of osteoblastic cells cultured on titanium and structured zirconia surfaces
9
Sulforaphane reverses glucocorticoid-induced apoptosis in osteoblastic cells through regulation of the Nrf2 pathway
10
Dichloroacetic Acid (DCA) Induced Cytotoxicity in Human Breast Cancer Cells Accompanies Changes in Mitochondrial Membrane Permeability and Production of Reactive Oxygen Species
16
The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells
6
AN OVERVIEW OF BONE CELLS AND THEIR REGULATING FACTORS OF DIFFERENTIATION
9
The role of kaempferol induced autophagy on differentiation and mineralization of osteoblastic MC3T3 E1 cells
10
Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low turnover osteopenia
10
Regulation of Osteoblastic Differentiation: A Concept Note
7
Vesicular trafficking in osteoblasts
327
Preparation and characterization of biomimetic silk fibroin/chitosan composite nanofibers by electrospinning for osteoblasts culture
11
The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models
12